The OSCTR is funded by the National Institutes of Health as part of its IDeA-CTR program. We have the mission to serve as a catalyst for clinical and translational research that improves health and healthcare for Oklahomans, to provide training and infrastructure to help junior investigators to launch independent research careers, and to expand the opportunities of IDeA states and Oklahoma communities to participate in research that improves the health of our residents.
Specialty
Areas
-
Cancer
-
Autoimmunity
-
Critical Care
-
Cardiology
Prioritized Clinical Trial Phases
-
Phase I
-
Phase II
-
Phase III
-
Phase IV
Trial Activation
Time
- Average turnaround time for Clinical Trial Agreements, Budget Negotiations, and IRB approval is 18 weeks
Site Highlights
-
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua
​​
-
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua
​​
- Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua
​
Learn More about OSCTR
​​
-
To learn more and connect with the The OSCTR, contact Brittany Karfonta